Portal de Periódicos da CAPES

Transmission of Epstein – Barr Virus During Transplantation

1996; Wiley; Volume: 6; Issue: 2 Linguagem: Inglês

10.1002/(sici)1099-1654(199606)6

1099-1654

Tanzina Haque, D. H. Crawford,

Cytomegalovirus and herpesvirus research

Reviews in Medical VirologyVolume 6, Issue 2 p. 77-84 Research Article Transmission of Epstein – Barr Virus During Transplantation T. J. Haque, T. J. Haque Department of Clinical Sciences, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UKSearch for more papers by this authorD. H. Crawford, D. H. Crawford Department of Clinical Sciences, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UKSearch for more papers by this author T. J. Haque, T. J. Haque Department of Clinical Sciences, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UKSearch for more papers by this authorD. H. Crawford, D. H. Crawford Department of Clinical Sciences, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UKSearch for more papers by this author First published: June 1996 https://doi.org/10.1002/(SICI)1099-1654(199606)6:2 3.0.CO;2-CCitations: 7AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Henle, G., Henle, W. and Diehl, W., (1968) Relation of Burkitt's tumour-associated herpes-type virus to infectious mononucleosis. Proc. Natl Acad. Sci. USA. 59, 94–101. 2 Epstein, M. A., Achong, B. G. and Barr, Y. M., (1964) Virus particles in cultured lymphoblasts from Burkitt lymphoma. Lancet 1, 702–703. 3 Crawford, D. H., Epstein, M. A., Bornkamn, G. W., Achong, B. G., Finerty, S. and Thompson, J. L., (1980) Epstein-Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in a patient with renal allograft. Lancet 1, 1355–1356. 4 Zeigler, J. I., Beckstead, J. A. and Volberding, P. A., (1984) Non-Hodgkin's lymphoma in 90 homosexual men: relation to generalised lymphadenopathy and the acquired immunodeficiency syndrome. N. Engl. J. Med. 311, 565–570. 5 Weiss, L. M., Movahed, L. A., Warnke, R. A. and Sklar, J., (1989) Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N. Engl. J. Med. 320, 502–506. 6 Klein, G., (1979) The relationship of the virus to nasopharyngeal carcinoma. In, The Epstein-Barr Virus, ed. by M. A. Epstein and B. G. Achong, pp. 339–350. Springer-Verlag, Berlin, Heidelberg and New York. 7 Greenspan, J. S., Greenspan, D. and Lennette, E. T., (1985) Replication of Epstein-Barr virus within the epithelial cells of ‘hairy’ leukoplakia, an AIDS-associated lesion. N. Engl. J. Med. 313, 1564–1571. 8 Raab-Traub, N., Rajadurai, P., Flynn, K. and Lanier, A. P., (1991) Epstein-Barr virus infection in carcinoma of the salivary glands. J. Virol. 65, 7032–7036. 9 Imai, S., Koizumi, S. and Sugiura, M., (1994) Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc. Natl Acad. Sci. USA. 91, 9131–9135. 10 Jones, J. F., Shurin, S., Abramowsky, C., et al. (1988) T cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infection. N. Engl. J. Med. 318, 733–741. 11 Dimery, I. W., Lee, J. S., Blick, M., Pearson, G., Spitzer, G. and Hong, W. K., (1988) Association of the Epstein-Barr virus with lymphoepitheliomas of the thymus. Cancer 61, 2475–2480. 12 Gaffey, M. J., Frierson, H. F., Medeiros, L. J. and Weiss, L. M., (1993) The relationship of Epstein-Barr virus to infection-related (sporadic) and familial haemophagocytic syndrome and secondary (lymphoma-related) haemophagocytosis: an in situ hybridisation study. Human Pathol. 24, 657–667. 13 Lee, E. S., Locker, J., Nalesnik, M., Reyes, J., Jaffe, R., Alashari, M., Nour, B., Tzakis, A. and Dickman, P. S., (1995) The association of Epstein-Barr virus with smooth-muscle tumours occurring after organ transplantation. N. Engl. J. Med. 332, 19–25. 14 Pope, J. H., Home, M. K. and Scott, W., (1968) Transformation of human foetal leucocytes in vitro by infiltrates of a human leukaemia cell line containing herpes-like virus. Int. J. Cancer 3, 857–866. 15 Kieff, E. and Leibowitz, D., (1990) Epstein-Barr virus and its replication. In, Virology, 2nd edn, ed. by B. N. Fields and D. M. Knipe, pp. 1889–1920. Raven Press, New York. 16 Robertson, E. S. and Kieff, E. D., (1995) Genetic analysis of Epstein-Barr virus in B lymphocytes. Epstein-Barr Virus Report 2 (4), 73–80. 17 Herrero, J. A., Mathew, P. and Paya, C. V., (1995) LMP-1 activates NF-kB by targeting the inhibitory molecule 1kB. J. Virol. 69, 2168–2174. 18 Rowe, M., Lear, A. L., Croom-Carter, D., Davies, A. H. and Rickinson, A. B., (1992) Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. J. Virol. 66, 122–131. 19 zur Hausen, H., O'Neill, F. and Freese, U. K., (1978) Persisting oncogenic herpesvirus induced by the tumour promoter TPA. Nature 272, 373–375. 20 Luka, J., Kallin, B. and Klein, G., (1979) Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 94, 228–231. 21 Countryman, J., Jenson, H., Seibl, R., Wolf, H. and Miller, G., (1987) Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupts latency. J. Virol. 61, 3672–3679. 22 Henle, G. and Henle, W., (1979) The virus as the etiologic agent of infectious mononucleosis. In, The Epstein-Ban Virus ed. by M. A. Epstein and B. G. Achong, pp. 297–320. Springer-Verlag, Berlin. 23 Sixbey, J. W., Nedrud, J. G., Raab-Traub, N., Hanes, R. A. and Pagano, J. S., (1984) Epstein-Barr virus replication in oropharyngeal epithelial cells. N. Engl. J. Med. 310, 1225–1230. 24 Rocchi, G., Felici, A. D., Ragona, G. and Heinz, A., (1977) Quantitative evaluation of Epstein-Barr virus-infected mononuclear peripheral blood leukocytes in infectious mononucleosis. N. Engl. J. Med. 296, 132–134. 25 Miyashita, E. M., Yang, B., Lam, K. M. C., Crawford, D. H. and Thorley-Lawson, D. A., (1995) A novel form of Epstein-Barr virus latency in normal B cells. Cell 80, 593–601. 26 Tierney, R. J., Steven, N., Young, L. S. and Rickinson, A. B., (1994) Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J. Virol. 68, 7374–7385. 27 Yao, Q. Y., Ogan, P., Rowe, M., Wood, M. and Rickinson, A. B., (1989) Epstein-Barr virus immortalised B-cells persist in the circulation of acyclovir-treated virus carriers. Int. J. Cancer 43, 67–71. 28 Moss, D. J., Wallace, L. E., Rickinson, A. B. and Epstein, M. A., (1981) Cytotoxic T-cell recognition of Epstein-Barr virus infected B-cells. I specificity and HLA-restriction of effector cells reactivated in vitro. Eur. J. Immunol. 11, 686–693. 29 Wallace, C. E., Rickinson, A. B., Rowe, M. and Epstein, M. A., (1982) Epstein-Barr virus-specific cytotoxic T-cell clones restricted through a single HLA antigen. Nature 297, 413–415. 30 Murray, R. J., Kurilla, S. R., Moss, D. J., et al. (1990) Human cytotoxic T cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses. Proc. Natl Acad. Sci. USA 87, 2906–2910. 31 Kyaw-Tanner, M., Esmore, D., Burrows, S. R., Benson, E. M. and Sculley, T. B., (1994) Epstein-Barr virus-specific cytotoxic T cell response in cardiac transplant recipients. Transplantation 57, 1611–1617. 32 Savoie, A., Perpete, C., Carpentier, L., Joncas, J. and Alfieri, C., (1994) Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of paediatric transplant patients and risk of lymphoproliferative disease. Blood 9, 2715–2722. 33 Ho, M., Miller, G., Wayne, A., et al. (1985) Epstein-Barr virus infection and DNA hybridisation studies in post-transplant lymphomas and lymphoproliferative lesions: the role of primary infection. J. Infect. Dis. 152, 876–886. 34 Ho, M., Jaffe, R., Miller, G., et al. (1988) The frequency of Epstein-Barr virus infection and associated lymphoproliferative disease after transplantation and its manifestations in children. Transplantation 45, 719–727. 35 Kroes, A. C. M., Brouwer, M. L., van Batenburg, M. and Balk, A. H. M. M., (1991) Primary Epstein-Barr virus (EBV) infection in an immunosuppressed patient: symptoms: serology and T cell response. J. Infect. Dis. 163, 1385–1387. 36 Thomas, J. A., Crawford, D. H. and Burke, M., (1995) Clinicopathological implications of Epstein-Barr virus related B cell lymphoma in immunocompromised patients. J. Clin. Pathol. 48, 287–290. 37 Penn, I. and Porat, G., (1995) Central nervous system lymphomas in organ allograft recipients. Transplantation 59, 240–244. 38 Nalesnik, M. A., (1990) Involvement of the gastrointestinal tract by Epstein-Barr virus-associated post-transplant lymphoproliferative disorders. Am. J. Surg. Pathol. 14 (supp. 1), 92–100. 39 Thomas, J. A., Hotchin, N. A., Allday, M. J., et al. (1990) Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals. Transplantation 49, 292–301. 40 Birkeland, S. A., (1983) Cancer in cadaver kidney transplant patients. Surgery 93, 504–507. 41 Starzl, T. F., Proter, D. A. and Iwatusuki, S., (1984) Reversibility of lymphomas or lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet i, 583–587. 42 Renard, T. H., Andrews, W. S. and Foster, M. E., (1991) Relationship between OKT3 administration, EBV seroconversion and the lymphoproliferative syndrome in pediatric liver transplant recipients. Transplant Proc. 23, 1473–1476. 43 Cox, K. L., Lawrence-Miyasaki, L. S., Garcia-Kennedy, R., et al. (1995) An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation 59, 524–529. 44 Beveridge, T., Krupp, P. and McKibbin, C., (1984) Lymphomas and lymphoproliferative lesions developing under cyclosporin therapy. Lancet i, 788. 45 Shapiro, R. S., McClain, K., Frizzera, G., et al. (1988) Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 71, 1234. 46 Nasesnik, M. A., Jaffe, R., Starzl, T. E., et al. (1988) The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporin A-prednisone immunosuppression. Am. J. Pathol. 133, 173–192. 47 Armitage, J. M., Kormos, R. L., Stuart, S., et al. (1991) Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporin-based immunosuppression. J. Heart. Lung. Transplant. 10, 877–887. 48 Randhawa, P. S., Yousem, S. A., Paradis, I. L., Dauber, J. A., Griffith, B. P. and Locker, J., (1989) The clinical spectrum, pathology and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heart-lung transplant recipients. Am. J. Clin. Pathol. 92, 177–185. 49 Alfrey, E. J., Friedman, A. L., Grossman, R. A., et al. (1992) A recent decrease in the time to development of monomorphous and polymorphous post-transplant lymphoproliferative disorder. Transplantation 54, 250–253. 50 Kino, T., Hatanaka, H. and Miyata, S., (1987) FK-506, a novel immunosuppressant isolated from Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J. Antibiot. 40, 1256–1265. 51 Opelz, G. and Henderson, R., (1993) Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 342, 1514–1516. 52 Weiss, L. M. and Movahed, L. A., (1989) in situ demonstration of Epstein-Barr viral genomes in viral-associated B lymphoproliferation. Am. J. Pathol. 134, 651–659. 53 Young, L., Alfieri, C. and Hennesy, K., (1989) Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N. Engl. J. Med. 321, 1080–1085. 54 Hunt, B. J., Thomas, J. A., Burke, M., Walker, H., Yacoub, M. and Crawford, D. H., (1996) Epstein-Barr virus associated Burkitt's lymphoma in a heart transplant recipient. Submitted to Transplantation. 55 Nalesnik, M. A., Locker, J. and Jaffe, R., (1992) Experience with lymphoproliferative disorders in organ transplant recipients. Clin. Transplant. 6, 249–252. 56 Hanto, D. W., Frizzera, G., Gajl-Peczalska, K. J., et al. (1982) Acyclovir therapy and transition from poly-clonal to monoclonal B cell proliferation. N. Engl. J. Med. 306, 913–918. 57 Pirsch, J. D., Stratta, R. J. and Sollinger, H. W., (1989) Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with Ganciclovir: two cases after organ transplantation. Am. J. Med. 86, 241–244. 58 Lin, J. C., Smith, M. C. and Pagano, J. S., (1981) Induction of replication of Epstein-Barr virus DNA by 12-O-tetradecanoyl-phorbol-13-acetate. II. Inhibition by retnoic acid and 9-(2-hydroxyethoxymethyl)guanine. Virology 3, 294–298. 59 Fischer, A., Blanche, S., Le Bidois, J., et al. (1991) Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N. Engl. J. Med. 324, 1451–1457. 60 Papadopoulos, E. B., Ladanyi, M. and Emmanuel, D., (1994) Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogenic bone marrow transplantation. N. Engl. J. Med. 330, 1185. 61 Rooney, C. M., Smith, C. A. and Ng, C. Y. C., (1995) Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation. Lancet 345, 9–12. 62 Burman, K. and Crawford, D. H., (1991) Effect of FK506 on Epstein-Barr virus specific cytotoxic T cells. Lancet 337, 297–298. 63 Tsoukas, C. D., Carson, D. A., Fong, S. and Vaughan, J. H., (1982) Molecular interactions in human T cell-mediated cytotoxicity to EBV II. Monoclonal antibody OKT3 inhibits a post-killer recognition/ adhesion step. J. Immunol. 129, 1421–1425. 64 Patton, D. F., Chris, W. W., Curtis, A. H., et al. (1990) Epstein-Barr virus determined clonality in post-transplant lymphoproliferative diseases. Transplantation 49, 1080–1084. 65 Tosato, G., Tanner, J., Jones, K. D., Revel, M. and Pike, S. E., (1990) Identification of interleukin 6 as an autocrine growth factor for Epstein-Barr virus-immortalised B cells. J. Virol. 64, 3033–3041. 66 O'Garra, A., Stapleton, G. and Dhar, V., (1990) Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int. Immunol. 2, 821–832. 67 Locker, J. and Nalesnik, M., (1989) Molecular genetics analysis of lymphoid tumours arising after organ transplantation. Am. J. Pathol. 135, 977–987. 68 Baer, R., Bankier, A. T., Biggin, M. D., et al. (1984) DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310, 207–211. 69 Gratama, J. W., Oosterveer, M. A. P., Zwaan, F. E., Lepoutre, J., Klein, G. and Ernberg, I., (1988) Eradication of Epstein-Barr virus by allogenic bone marrow transplantation: Implications for sites of viral latency. Proc. Natl Acad. Sic USA 85, 8693–8696. 70 Gratama, J. W., Oosterveer, M. A. P., Lepoutre, J. M. M., et al. (1990) Serological and molecular studies of Epstein-Barr virus infection in allogenic marrow graft recipients. Transplantation 49, 725–730. 71 Van Gelder, T., Kroes, L. C. M., Mulder, A., Gratama, J. W. and Weimer, W., (1994) A living-related kidney donor as the source of a nearly fatal primary Epstein-Barr virus infection following transplantation. Transplantation 58, 852–855. 72 Cen, H., Breinig, M. C., Atchison, R. W., Ho, M. and McKnight, J. L., (1991) Epstein-Barr virus transmission via the donor organ in solid organ transplantation: Polymerase chain reaction and restriction fragment length polymorphism analysis of IR2, IR3 and IR4. J. Virol. 65, 976–980. 73 Epstein, M. A., Morgan, A. J., Finerty, S., Randle, B. J. and Kirkwood, J. K., (1985) Protection of cotton-top tamarins against EB virus-induced malignant lymphoma by a prototype subunit vaccine. Nature 318, 287–289. Citing Literature Volume6, Issue2June 1996Pages 77-84 ReferencesRelatedInformation